These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 33350744)

  • 21. Vasovagal reactions in whole blood donors at three REDS-II blood centers in Brazil.
    Gonçalez TT; Sabino EC; Schlumpf KS; Wright DJ; Leao S; Sampaio D; Takecian PL; Proietti AB; Murphy E; Busch M; Custer B;
    Transfusion; 2012 May; 52(5):1070-8. PubMed ID: 22073941
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Delayed adverse events in male plateletpheresis donors: Initial insights on donor safety.
    Gupta AM; Bajpai M
    J Clin Apher; 2020 Jan; 35(1):18-24. PubMed ID: 31663633
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Donation related fears predict vasovagal reactions and donor attrition among high school donors.
    France CR; France JL; Himawan LK; Lux P; McCullough J
    Transfusion; 2021 Jan; 61(1):102-107. PubMed ID: 32997822
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vasovagal reactions in 'at risk' donors: a univariate analysis of effect of age and weight on the grade of donor reactions.
    Tondon R; Pandey P; Chaudhary R
    Transfus Apher Sci; 2008 Oct; 39(2):95-9. PubMed ID: 18753009
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Plateletpheresis in 90- to 110-pound donors using the CS-3000 blood cell separator.
    Buchholz DH; Squires JE; Herman JH; Ng AT; Anderson JK; Hedberg SL
    Transfusion; 1997 Jul; 37(7):715-8. PubMed ID: 9225935
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Donor vigilance data of a blood transfusion service: A multicenter analysis.
    Burkhardt T; Dimanski B; Karl R; Sievert U; Karl A; Hübler C; Tonn T; Sopvinik I; Ertl H; Moog R
    Transfus Apher Sci; 2015 Oct; 53(2):180-4. PubMed ID: 26074050
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Risk factors associated with the occurrence of adverse events in plateletpheresis donation.
    Barbosa MH; da Silva KF; Coelho DQ; Tavares JL; da Cruz LF; Kanda MH
    Rev Bras Hematol Hemoter; 2014; 36(3):191-5. PubMed ID: 25031058
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interventions to reduce vasovagal reactions in blood donors: a systematic review and meta-analysis.
    Fisher SA; Allen D; Dorée C; Naylor J; Di Angelantonio E; Roberts DJ
    Transfus Med; 2016 Feb; 26(1):15-33. PubMed ID: 27061617
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Incidence and risk predictors analysis of adverse donor reactions in whole blood donation.
    Prakash S; Das PK; Mishra D; Ray GK; Routray S; Naik A; Mukherjee S
    Transfus Clin Biol; 2020 Nov; 27(4):207-212. PubMed ID: 33027707
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Development and validation of a nomogram for predicting the risk of vasovagal reactions after plasma donation.
    Zhao P; Dong D; Dong R; Zhou Y; Hong Y; Xiao G; Li Z; Su X; Zheng X; Liu X; Zhang D; Li L; Liu Z
    J Clin Apher; 2023 Oct; 38(5):622-631. PubMed ID: 37466252
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The potential impact of selective donor deferrals based on estimated blood volume on vasovagal reactions and donor deferral rates.
    Rios JA; Fang J; Tu Y; Wright DJ; Spencer B; Hillyer CD; Hillyer KL; Eder AF; Benjamin RJ;
    Transfusion; 2010 Jun; 50(6):1265-75. PubMed ID: 20113451
    [TBL] [Abstract][Full Text] [Related]  

  • 32. National audit of citrate toxicity in plateletpheresis donors.
    Makar YF; Butler MO; Cockersole GM; Gabra G; Serevitch JM
    Transfus Med; 2002 Jun; 12(3):187-91. PubMed ID: 12071875
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevalence and predictors of adverse reactions in plateletpheresis donors with the perspective of donor safety in a tertiary care hospital of Northern India.
    Solanki A; Katharia R; Singh A; Chauhan A; Chandra T; Sonker A; Agarwal P
    Asian J Transfus Sci; 2020; 14(1):44-48. PubMed ID: 33162705
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of a liberal versus a restrictive pre-donation blood pressure policy on whole-blood donor adverse reactions.
    Salvadori U; Sandri M; Cemin R; Al-Khaffaf A; Daves M; Maniscalco F; Hueber R; Troi C; Griessmair A; Ploner F; Egger K; Kuehebacher G; Gentilini I; Vecchiato C
    Vox Sang; 2019 May; 114(4):317-324. PubMed ID: 30883806
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rates of vaso-vagal reactions among first time teenaged whole blood, double red cell, and plateletpheresis donors.
    Reiss RF; Harkin R; Lessig M; Mascari J
    Ann Clin Lab Sci; 2009; 39(2):138-43. PubMed ID: 19429799
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Changes in pre- and post-donation platelet function in plateletpheresis donors.
    Zhou Q; Yu X; Cai Y; Liu L
    Transfus Clin Biol; 2017 Nov; 24(4):417-421. PubMed ID: 28599950
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vasovagal syncope after blood donation in active duty military personnel of the Spanish Army.
    Fraile N; Fernández-Cano E; Ramos A; López-Aguilar JC; Jiménez-Moreno ME; Pereira A
    Transfusion; 2021 Oct; 61(10):2925-2929. PubMed ID: 34414580
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An intervention study for the prevention of vasovagal reactions and evaluating donors' experience: Analysis of donors' return for subsequent donation.
    Wiersum-Osselton J; Prinsze F; van den Brekel E; van Dongen A; Hermans F; Bokhorst A; der Kreek TM
    Vox Sang; 2022 Mar; 117(3):313-320. PubMed ID: 34396539
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adverse events and retention of donors of double red cell units by apheresis.
    Keshelashvili K; O'meara A; Stern M; Jirout Z; Pehlic V; Holbro A; Buser A; Sigle J; Infanti L
    Blood Transfus; 2016 Sep; 14(5):391-9. PubMed ID: 27136442
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Plateletpheresis-associated lymphopenia in frequent platelet donors.
    Gansner JM; Rahmani M; Jonsson AH; Fortin BM; Brimah I; Ellis M; Smeland-Wagman R; Li ZJ; Schenkel JM; Brenner MB; Yefidoff-Freedman R; Sloan SR; Berliner N; Issa NC; Baden LR; Longo DL; Wesemann DR; Neuberg D; Rao DA; Kaufman RM
    Blood; 2019 Feb; 133(6):605-614. PubMed ID: 30429159
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.